Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Medidata Rave Safety | Statement: [Medidata Solutions, product, Medidata Rave Safety]

Target entity: Medidata Rave Safety
Context triple: [Medidata Solutions, product, Medidata Rave Safety]

• A. Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
  Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs (ICH E2C) is an international guideline that standardizes the format, content, and timing of periodic safety reports submitted by marketing authorization holders to monitor and communicate the ongoing safety profile of approved medicines.
• B. ICH E2A Clinical Safety Data Management
  ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.
• C. Medidata Solutions
  Medidata Solutions is a life sciences technology company best known for its cloud-based clinical trial and research platforms used by pharmaceutical, biotech, and medical device organizations.
• D. Regenstrief Medical Record System
  The Regenstrief Medical Record System is an early, pioneering electronic medical record platform that helped shape modern health informatics and clinical data management practices.
• E. FDA Risk Evaluation and Mitigation Strategies authority
  The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Medidata Rave Safety
Target entity description: Medidata Rave Safety is a pharmacovigilance and safety management solution within Medidata’s clinical research platform that helps life sciences organizations collect, manage, and report adverse event data in clinical trials.

• A. Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
  Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs (ICH E2C) is an international guideline that standardizes the format, content, and timing of periodic safety reports submitted by marketing authorization holders to monitor and communicate the ongoing safety profile of approved medicines.
• B. ICH E2A Clinical Safety Data Management
  ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.
• C. Medidata Solutions chosen
  Medidata Solutions is a life sciences technology company best known for its cloud-based clinical trial and research platforms used by pharmaceutical, biotech, and medical device organizations.
• D. Regenstrief Medical Record System
  The Regenstrief Medical Record System is an early, pioneering electronic medical record platform that helped shape modern health informatics and clinical data management practices.
• E. FDA Risk Evaluation and Mitigation Strategies authority
  The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
• F. None of above.